Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An announcement from Biophytis SA ( (FR:ALBPS) ) is now available.
Biophytis SA has successfully raised approximately 2.6 million euros through a private placement, issuing new shares and pre-funded share subscription warrants. The funds will be used to accelerate the development of their clinical programs, particularly for BIO101 in obesity and sarcopenia, support regulatory activities, and extend the company’s cash flow until the third quarter of 2025, reflecting investor confidence in Biophytis’s strategic direction and potential.
More about Biophytis SA
Biophytis SA is a clinical-stage biotechnology company focused on developing treatments for age-related diseases. The company is engaged in advancing clinical programs aimed at addressing significant unmet medical needs, particularly in the areas of obesity and sarcopenia.
YTD Price Performance: -16.00%
Average Trading Volume: 18,486
Technical Sentiment Signal: Buy
Current Market Cap: €4.33M
Learn more about ALBPS stock on TipRanks’ Stock Analysis page.